|
ABUS Arbutus Biopharma Corp 1447028 |
| Balance Sheet |
|
Current Assets
|
$277,011,000.00 |
|
Assets
|
$277,164,000.00 |
|
Current Liabilities
|
$5,105,000.00 |
|
Liabilities
|
$16,987,000.00 |
|
Equity
|
$260,177,000.00 |
|
Shares Out
|
196947757.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,110,000.00 |
|
Investing Cash Flow
|
$2,199,000.00 |
| Market Analysis |
Market Cap
|
$868,539,608.37 |
|
Price
|
$4.37 |
|
BVPS
|
1.32 |
|
PB
|
3.34 |
|
EPS
|
0.88 |
|
PE
|
5.57 |
|
PS
|
1.34 |
|
FCF
|
$-8,110,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-23 |
-0.17 |
|
|
2026-05-13 |
0.87 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABUS documents filed with the SEC.
ABUS Filings
Clear
